{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:12:33Z","timestamp":1793776353212,"version":"4.6.1"},"reference-count":188,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Ta434\/8-1"],"award-info":[{"award-number":["Ta434\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB\/TRR 296"],"award-info":[{"award-number":["SFB\/TRR 296"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["403224013"],"award-info":[{"award-number":["403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1382"],"award-info":[{"award-number":["CRC1382"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cmet.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T10:37:27Z","timestamp":1717151847000},"page":"1439-1455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":452,"title":["Metabolic reprogramming in liver fibrosis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-7703","authenticated-orcid":false,"given":"Paul","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/hep.23754","article-title":"Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation","volume":"52","author":"Dech\u00eane","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.cmet.2024.05.003_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","article-title":"Matrix as a modulator of hepatic fibrogenesis","volume":"21","author":"Schuppan","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cmet.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jhep.2021.02.012","article-title":"Targeting cell-intrinsic metabolism for antifibrotic therapy","volume":"74","author":"Gilgenkrantz","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH","volume":"79","author":"Tacke","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.cmet.2024.05.003_bib12","series-title":"International Review of Cell and Molecular Biology One, No One, One Hundred Thousand - The Multifaceted Role of Macrophages in Health and Disease - Part B","first-page":"143","article-title":"Chapter five - Macrophages as key regulators of liver health and disease","author":"Papachristoforou","year":"2022"},{"key":"10.1016\/j.cmet.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2014from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2024.05.003_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cmet.2024.05.003_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cmet.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib20","doi-asserted-by":"crossref","first-page":"eadd8945","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2024.05.003_bib22","article-title":"Vascular endothelial growth factor promotes fibrosis resolution and repair in mice","volume":"146","author":"Yang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3389\/fimmu.2019.02670","article-title":"Contribution of macrophage efferocytosis to liver homeostasis and disease","volume":"10","author":"Horst","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cmet.2024.05.003_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166954","article-title":"Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models","volume":"133","author":"Feng","year":"2023","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cmet.2024.05.003_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","article-title":"Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression","volume":"78","author":"Guillot","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HEP.0000000000000557","article-title":"Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis","volume":"79","author":"De Muynck","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1486","article-title":"The immunologic Warburg effect: evidence and therapeutic opportunities in autoimmunity","volume":"12","author":"Kornberg","year":"2020","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 11","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the Warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib33","doi-asserted-by":"crossref","first-page":"101634","DOI":"10.1016\/j.redox.2020.101634","article-title":"Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH","volume":"36","author":"Xu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.cmet.2024.05.003_bib34","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.7150\/ijbs.73890","article-title":"Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease","volume":"18","author":"Fan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cmet.2024.05.003_bib35","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cmet.2024.05.003_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/db18-0035","article-title":"HSPA12A is a novel player in nonalcoholic steatohepatitis via promoting nuclear PKM2-mediated M1 macrophage polarization","volume":"68","author":"Kong","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.003_bib37","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41467-021-21461-4","article-title":"Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation","volume":"12","author":"Jones","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2024.05.003_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42255-023-00736-8","article-title":"PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages","volume":"5","author":"Schilperoort","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2024.05.003_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","article-title":"UCP1 governs liver extracellular succinate and inflammatory pathogenesis","volume":"3","author":"Mills","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cmet.2018.10.015","article-title":"Hepatocyte-macrophage acetoacetate shuttle protects against tissue fibrosis","volume":"29","author":"Puchalska","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cmet.2022.01.004","article-title":"A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis","volume":"34","author":"Loft","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"Leroux","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib45","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"Govaere","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1\u03b2\u2013dependent suppression of peroxisome proliferator-activated receptor \u03b1 activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2024.05.003_bib49","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-\u03b1 production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.003_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2022.02.031","article-title":"Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis","volume":"77","author":"Wang","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2011.12.018","article-title":"FAT SIGNALS - lipases and lipolysis in lipid metabolism and signaling","volume":"15","author":"Zechner","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gutjnl-2018-316137","article-title":"Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver","volume":"68","author":"Habib","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cmet.2024.05.003_bib53","doi-asserted-by":"crossref","first-page":"100794","DOI":"10.1016\/j.jhepr.2023.100794","article-title":"Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration","volume":"5","author":"Allaire","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib54","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-023-37453-5","article-title":"MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming","volume":"14","author":"Mabire","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2024.05.003_bib55","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni.1857","article-title":"TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages","volume":"11","author":"Martinon","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib58","doi-asserted-by":"crossref","first-page":"100555","DOI":"10.1016\/j.jhepr.2022.100555","article-title":"XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression","volume":"4","author":"Wang","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib60","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","article-title":"Macrophage autophagy protects against liver fibrosis in mice","volume":"11","author":"Lodder","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.cmet.2024.05.003_bib61","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/liv.15547","article-title":"Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85","volume":"43","author":"Zhang","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.cmet.2024.05.003_bib62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2016.12.004","article-title":"Autophagy-deficient Kupffer cells promote tumorigenesis by enhancing mtROS-NF-\u03baB-IL1\u03b1\/\u03b2-dependent inflammation and fibrosis during the preneoplastic stage of hepatocarcinogenesis","volume":"388","author":"Sun","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cmet.2024.05.003_bib63","doi-asserted-by":"crossref","first-page":"eaaw8523","DOI":"10.1126\/scitranslmed.aaw8523","article-title":"LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling","volume":"12","author":"Wan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib64","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s42255-023-00928-2","article-title":"Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype","volume":"5","author":"Maus","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib65","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/JLB.3A0318-108R","article-title":"Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis","volume":"105","author":"Handa","year":"2019","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.cmet.2024.05.003_bib66","doi-asserted-by":"crossref","first-page":"102032","DOI":"10.1016\/j.isci.2020.102032","article-title":"Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH","volume":"24","author":"Kanamori","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.cmet.2024.05.003_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41419-022-04775-z","article-title":"Interaction between macrophages and ferroptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2024.05.003_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2024.05.003_bib69","doi-asserted-by":"crossref","first-page":"100695","DOI":"10.1016\/j.jhepr.2023.100695","article-title":"TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling","volume":"5","author":"Su","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib70","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/ijms23052668","article-title":"Nuclear receptors linking metabolism, inflammation, and fibrosis in nonalcoholic fatty liver disease","volume":"23","author":"Puengel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2024.05.003_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib72","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.106.684704","article-title":"Macrophage expression of peroxisome proliferator\u2013activated receptor-\u03b1 reduces atherosclerosis in low-density lipoprotein receptor\u2013deficient mice","volume":"116","author":"Babaev","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cmet.2024.05.003_bib73","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.26732","article-title":"Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia","volume":"59","author":"Jha","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and\u00a0fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.cmet.2024.05.003_bib75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages\u2606","volume":"73","author":"Lefere","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib76","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cmet.2008.04.003","article-title":"Alternative M2 activation of Kupffer cells by PPAR\u03b4 ameliorates obesity-induced insulin resistance","volume":"7","author":"Odegaard","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib77","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/1873-3468.14474","article-title":"Novel insights into the regulation of cellular catabolic metabolism in macrophages through nuclear receptors","volume":"596","author":"Stifel","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cmet.2024.05.003_bib78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12950-015-0081-4","article-title":"The PPAR-\u03b3 antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK\/Gas6 axis: a key role for PPAR-\u03b3 in human macrophage polarization","volume":"12","author":"Zizzo","year":"2015","journal-title":"J.\u00a0Inflamm. (Lond)"},{"key":"10.1016\/j.cmet.2024.05.003_bib79","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1101\/gad.312355.118","article-title":"PPAR\u03b3 is a nexus controlling alternative activation of macrophages via glutamine metabolism","volume":"32","author":"Nelson","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.cmet.2024.05.003_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.cellbio.20.012103.134432","article-title":"Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation","volume":"20","author":"Castrillo","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.cmet.2024.05.003_bib81","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2004.09.032","article-title":"LXR-dependent gene expression is important for macrophage survival and the innate immune response","volume":"119","author":"Joseph","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib82","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/ATVBAHA.122.317583","article-title":"Myeloid LXR (liver X receptor) deficiency induces inflammatory gene expression in foamy macrophages and accelerates atherosclerosis","volume":"42","author":"Endo-Umeda","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cmet.2024.05.003_bib83","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/en.2017-03141","article-title":"Dysregulation of Kupffer cells\/macrophages and natural killer T\u00a0cells in steatohepatitis in LXR\u03b1 knockout male mice","volume":"159","author":"Endo-Umeda","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2024.05.003_bib84","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1074\/jbc.M112.446575","article-title":"Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease","volume":"288","author":"McMahan","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.003_bib85","doi-asserted-by":"crossref","first-page":"1065790","DOI":"10.3389\/fimmu.2023.1065790","article-title":"Stimulation of the farnesoid X receptor promotes M2 macrophage polarization","volume":"14","author":"Jaroonwitchawan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib86","doi-asserted-by":"crossref","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib87","article-title":"Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis","volume":"14","author":"Shi","year":"2022","journal-title":"Sci.\u00a0Transl. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib88","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcmgh.2023.12.011","article-title":"Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13-dependent fibrogenesis","volume":"17","author":"Rei\u00dfing","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T\u00a0cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib90","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T\u00a0cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2024.05.003_bib91","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T\u00a0cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cmet.2024.05.003_bib92","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"Moreno-Fernandez","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib93","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jcmgh.2020.06.001","article-title":"Acetyl-CoA carboxylase inhibition improves multiple dimensions of NASH pathogenesis in model systems","volume":"10","author":"Ross","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib94","doi-asserted-by":"crossref","first-page":"104778","DOI":"10.1016\/j.ebiom.2023.104778","article-title":"Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T\u00a0cell function and viability in liver disease","volume":"95","author":"Vaikunthanathan","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmet.2024.05.003_bib95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity\u2014metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib96","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib97","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","article-title":"CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis","volume":"159","author":"Mejias","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-019-0324-8","article-title":"Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.cmet.2024.05.003_bib99","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.ajpath.2020.08.002","article-title":"Pyruvate kinase M2 tetramerization protects against hepatic stellate cell activation and liver\u00a0fibrosis","volume":"190","author":"Zheng","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cmet.2024.05.003_bib100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","article-title":"Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis","volume":"35","author":"Rho","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib101","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1096\/fj.201802675R","article-title":"Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells","volume":"33","author":"Wan","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.cmet.2024.05.003_bib102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.hbpd.2021.04.010","article-title":"Mitochondria: a critical hub for hepatic stellate cells activation during chronic liver diseases","volume":"20","author":"Ezhilarasan","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.cmet.2024.05.003_bib103","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jcmm.13501","article-title":"Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin","volume":"22","author":"Gajendiran","year":"2018","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib104","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-022-05088-x","article-title":"Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2024.05.003_bib105","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/cells9112456","article-title":"Simultaneous induction of glycolysis and oxidative phosphorylation during activation of hepatic stellate cells reveals novel mitochondrial targets to treat liver fibrosis","volume":"9","author":"Smith-Cortinez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cmet.2024.05.003_bib106","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2024.01.032","article-title":"Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models","volume":"80","author":"Caon","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yexcr.2016.01.012","article-title":"Vitamin A and insulin are required for the maintenance of hepatic stellate cell quiescence","volume":"341","author":"Yoneda","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cmet.2024.05.003_bib108","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.003_bib109","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib110","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/s41598-022-19459-z","article-title":"FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models","volume":"12","author":"O\u2019Farrell","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib111","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","article-title":"Stearoyl-CoA desaturase promotes liver fibrosis and tumor development in mice via a Wnt positive-signaling loop by stabilization of low-density lipoprotein-receptor-related proteins 5 and 6","volume":"152","author":"Lai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2022.02.003","article-title":"Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis","volume":"77","author":"Fondevila","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib113","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib114","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2014.03.018","article-title":"Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells","volume":"61","author":"Tomita","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib116","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101660RR","article-title":"Differential cholesterol uptake in liver cells: a role for PCSK9","volume":"36","author":"Luquero","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.cmet.2024.05.003_bib117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajpath.2021.10.002","article-title":"A novel mouse model of nonalcoholic steatohepatitis suggests that liver fibrosis initiates around lipid-laden macrophages","volume":"192","author":"Ichimura-Shimizu","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cmet.2024.05.003_bib118","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.12.006","article-title":"Increased glutaminolysis marks active scarring in nonalcoholic steatohepatitis progression","volume":"10","author":"Du","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib120","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","article-title":"Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1\u03b1\/NF-\u03baB feedback pathway to inhibit liver fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cmet.2024.05.003_bib121","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-022-05409-0","article-title":"Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis","volume":"13","author":"Yin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2024.05.003_bib122","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cmet.2019.08.001","article-title":"Glutamate signaling in hepatic stellate cells drives alcoholic steatosis","volume":"30","author":"Choi","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib123","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/hep.20719","article-title":"NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells","volume":"41","author":"Adachi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045285","article-title":"NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development","volume":"7","author":"Sancho","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmet.2024.05.003_bib125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.07.013","article-title":"NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells","volume":"126","author":"Andueza","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib126","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.cmet.2024.05.003_bib127","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.510290346","article-title":"Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C\/EBPbeta-dependent mechanism in rat hepatic stellate cells","volume":"29","author":"Garc\u00eda-Trevijano","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2008.0036","article-title":"Evidence for activation of the TGF-\u03b21 promoter by C\/EBP\u03b2 and its modulation by Smads","volume":"29","author":"Abraham","year":"2009","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.cmet.2024.05.003_bib129","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.24281","article-title":"The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2\/gp91phox mediate hepatic fibrosis in mice","volume":"53","author":"Paik","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib130","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/hep.25938","article-title":"Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent","volume":"56","author":"Aoyama","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129743","article-title":"Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation","volume":"10","author":"Lan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cmet.2024.05.003_bib132","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41419-019-1327-5","article-title":"Unfolded protein response is an early, non-critical event during hepatic stellate cell activation","volume":"10","author":"Mannaerts","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2024.05.003_bib134","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.gastro.2015.09.039","article-title":"Endoplasmic reticulum stress in hepatic stellate cells promotes liver fibrosis via PERK-mediated degradation of HNRNPA1 and up-regulation of SMAD2","volume":"150","author":"Koo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib135","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.RA118.005761","article-title":"Transforming growth factor \u03b2 (TGF\u03b2) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation","volume":"294","author":"Liu","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cmet.2024.05.003_bib136","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28921","article-title":"The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice","volume":"65","author":"Maiers","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib137","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2013.02.016","article-title":"Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy","volume":"59","author":"Hern\u00e1ndez-Gea","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib138","doi-asserted-by":"crossref","first-page":"39342","DOI":"10.1038\/srep39342","article-title":"The XBP1 arm of the unfolded protein response induces fibrogenic activity in hepatic stellate cells through autophagy","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib139","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Cao","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cmet.2024.05.003_bib140","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib141","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","author":"Hern\u00e1ndez-Gea","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib142","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.cmet.2024.05.003_bib143","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cmet.2024.05.003_bib144","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2022.02.028","article-title":"m6A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells","volume":"182","author":"Shen","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib145","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.freeradbiomed.2022.11.011","article-title":"Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis","volume":"193","author":"Cho","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib146","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-024-00913-4","article-title":"Cell senescence in liver diseases: pathological mechanism and theranostic opportunity","volume":"21","author":"Sanfeliu-Redondo","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.03.014","article-title":"Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatotic liver disease","author":"Yashaswini","year":"2024","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib149","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T\u00a0cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2024.05.003_bib150","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1097\/HEP.0000000000000326","article-title":"Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver\u00a0fibrosis","volume":"77","author":"Du","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib151","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib152","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","article-title":"Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury","volume":"71","author":"Liu","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib153","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/gast.2003.50015","article-title":"Peroxisome proliferator-activated receptor-\u03b2 signaling contributes to enhanced proliferation of hepatic stellate cells","volume":"124","author":"Hellemans","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib154","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2045-3701-2-34","article-title":"GW501516-activated PPAR\u03b2\/\u03b4 promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation","volume":"2","author":"Kostadinova","year":"2012","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cmet.2024.05.003_bib155","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1053\/j.gastro.2010.11.053","article-title":"Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease","volume":"140","author":"Beaven","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib156","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.27645","article-title":"Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein","volume":"62","author":"O\u2019Mahony","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib157","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2353\/ajpath.2009.090114","article-title":"Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts","volume":"175","author":"Fickert","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cmet.2024.05.003_bib158","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib159","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2023.11.001","article-title":"Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module","volume":"80","author":"Bendixen","year":"2024","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/17446651.2022.2110864","article-title":"Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis","volume":"17","author":"Wirth","year":"2022","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib161","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/liv.15759","article-title":"Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells","volume":"44","author":"Manka","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.cmet.2024.05.003_bib162","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib163","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA Phase III randomized study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib164","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib165","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric\u2013metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cmet.2024.05.003_bib166","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/dom.14946","article-title":"A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes","volume":"25","author":"Saxena","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib167","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41401-019-0310-0","article-title":"WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in\u00a0mice","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cmet.2024.05.003_bib168","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","article-title":"GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease","volume":"155","author":"Loomba","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib169","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","article-title":"Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial","volume":"27","author":"Ratziu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2018.04.009","article-title":"Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models","volume":"31","author":"Esquejo","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmet.2024.05.003_bib171","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jacc.2013.05.050","volume":"62","author":"Ballantyne","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.cmet.2024.05.003_bib172","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib173","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2024.05.003_bib174","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s42995-023-00168-z","article-title":"Discovery of a natural small-molecule AMP-activated kinase activator that alleviates nonalcoholic steatohepatitis","volume":"5","author":"Chen","year":"2023","journal-title":"Mar. Life Sci. Technol."},{"key":"10.1016\/j.cmet.2024.05.003_bib175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2024.05.003_bib176","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41467-022-28271-2","article-title":"Pharmacologic IRE1\/XBP1s activation promotes systemic adaptive remodeling in obesity","volume":"13","author":"Madhavan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2024.05.003_bib177","doi-asserted-by":"crossref","first-page":"G965","DOI":"10.1152\/ajpgi.00132.2015","article-title":"Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat\/sugar diet","volume":"309","author":"Liu","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cmet.2024.05.003_bib178","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41418-020-00671-1","article-title":"Hepatocyte-specific deletion of XBP1 sensitizes mice to liver injury through hyperactivation of IRE1\u03b1","volume":"28","author":"Duwaerts","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cmet.2024.05.003_bib179","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2024.05.003_bib180","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/ncomms3300","article-title":"Overexpression of Atg5 in mice activates autophagy and extends lifespan","volume":"4","author":"Pyo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2024.05.003_bib181","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(99)70406-3","article-title":"Rapamycin inhibits hepatic stellate cell proliferation in\u00a0vitro and limits fibrogenesis in an in\u00a0vivo model of liver fibrosis","volume":"117","author":"Zhu","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2024.05.003_bib182","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","article-title":"Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis","volume":"79","author":"Sanyal","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cmet.2024.05.003_bib183","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib184","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cmet.2024.05.003_bib185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fendo.2019.00350","article-title":"Thyroid hormone action on innate immunity","volume":"10","author":"Montesinos","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cmet.2024.05.003_bib186","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/pharmaceutics15051452","article-title":"PPAR-\u03b3 agonist GW1929 targeted to macrophages with dendrimer\u2013graphene nanostars reduces liver fibrosis and inflammation","volume":"15","author":"Moreno-Lanceta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cmet.2024.05.003_bib187","doi-asserted-by":"crossref","first-page":"100524","DOI":"10.1016\/j.jhepr.2022.100524","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.cmet.2024.05.003_bib188","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1038\/s41467-023-43917-5","article-title":"Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology","volume":"14","author":"Hu","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413124001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413124001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:42:05Z","timestamp":1731721325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413124001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":188,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1550413124001797"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2024.05.003","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}